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ABSTRACT: The balance between protein folding and misfolding is a crucial determinant of
amyloid assembly. Transient intermediates that are sparsely populated during protein folding have
been identiﬁed as key players in amyloid aggregation. However, due to their ephemeral nature,
structural characterization of these species remains challenging. Here, using the power of
nonuniformly sampled NMR methods we investigate the folding pathway of amyloidogenic and
nonamyloidogenic variants of β2-microglobulin (β2m) in atomic detail. Despite folding via common
intermediate states, we show that the decreased population of the aggregation-prone ITrans state and
population of a less stable, more dynamic species ablate amyloid formation by increasing the energy
barrier for amyloid assembly. The results show that subtle changes in conformational dynamics can
have a dramatic eﬀect in determining whether a protein is amyloidogenic, without perturbation of the
mechanism of protein folding.
■ INTRODUCTION
Protein unfolding is commonly associated with amyloid
formation. This view is supported by the large number of
intrinsically unfolded proteins that are the causative agents of
amyloid diseases, such as α-synuclein, amyloid-β peptide (Aβ),
and amylin.1−3 In terms of folded protein precursors, a link
between local or global unfolding and the onset of aggregation
has been documented.4 Indeed, decreased native state stability
and a reduction in co-operativity have been linked with
enhanced amyloidogenicity of several proteins, including
human lysozyme,5 transthyretin,6 prion protein,7 superoxide
dismutase (SOD),8 and β2-microglobulin (β2m).
9,10 These
ﬁndings have guided theoretical approaches to predict
aggregation-prone regions of folded proteins by combining
the intrinsic propensity of a protein sequence to self-assemble
with its probability to become exposed (e.g., by increased
predicted hydrogen-exchange rates).11,12 Along similar lines,
strategies to stabilize native-like conformations by the use of
small molecules,13,14 aptamers,15 molecular chaperones16,17 or
via other protein−protein interactions18,19 all reduce amyloid
formation. However, a quantitative link between the conforma-
tional properties and dynamics of individual partially folded
species and amyloid propensity remains elusive, in part because
of diﬃculties in identifying and characterizing amyloid
intermediates in atomic detail. In addition, the complexity of
the energy landscape of proteins, which involves many
potentially amyloidogenic species, exacerbates the intricacy of
the system.
In this study we investigate the structural, kinetic, and
thermodynamic properties of sparsely populated intermediates
of human and murine β2m (hβ2m, mβ2m, respectively) and link
their properties to the known, very diﬀerent amyloid
propensities of these proteins.20 Hβ2m forms amyloid ﬁbrils
in the joints of patients undergoing hemodialysis, in a
pathological condition known as dialysis-related amyloido-
sis.21,22 Previous studies have examined the link between the
folding pathway of β2m and its aggregation propensity. These
studies showed that hβ2m does not aggregate at neutral pH
unless additives such as Cu2+,23 triﬂuoroethanol (TFE),24 or
other cosolvents,25,26 which partially unfold the protein, are
added. As hβ2m contains a thermodynamically unfavorable cis
prolyl-peptide bond at position 32, protein folding involves a
slow folding phase which is attributed to trans−cis proline
isomerization of this bond.9,27 A native-like intermediate
containing a trans-Pro 32 (IT) accumulates during folding of
hβ2m, which can be trapped by removal of the N-terminal six
residues of the protein, to create the variant ΔN6.28,29 At
neutral pH, the concentration of IT correlates directly with the
rate of amyloid formation of hβ2m,
9 suggesting that formation
of this on-pathway native-like folding intermediate is a key
determinant of amyloid formation. This supposition is
conﬁrmed by the ability of ΔN6 to aggregate readily at pH
6.2.28 On the other hand, mβ2m, despite being 70% identical in
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sequence to hβ2m and also containing a cis-X Pro 32 bond,
does not form amyloid ﬁbrils at neutral pH, or even when
unfolded under acidic conditions (unless high concentrations of
salt are added) (Figure 1A and 1B).19,30 The basis of such
dramatically diﬀerent amyloid propensities despite the
sequence and structural similarities of these two proteins
remained unclear.
Here, we set out to investigate the molecular origins of the
reduced amyloidogenicity of mβ2m. We characterize the
stability, structure, and dynamics of the native protein and
show that despite its inability to form amyloid, mβ2m is
kinetically and thermodynamically less stable than its human
counterpart. The folding pathway of mβ2m is then explored
using real-time NMR, taking advantage of the power of
nonuniformly sampling (NUS) methods to reveal detailed
information on the energy landscape of mβ2m folding.
Combined with other biophysical methods, we show that
while mβ2m also folds through an IT state, this species is
relatively more ﬂexible than its hβ2m counterpart and in
conformational exchange with other, less-structured non-native
states.
The molten globule-like characteristics of the mβ2m folding
intermediate reduce the lifetime of the structured, well-folded
IT state, which now represents only a minor substate in the
structural ensemble. Our ﬁndings conﬁrm the vital role of IT
(and hence a highly structured, yet non-native species) in
determining the aggregation of β2m. Moreover, the results
highlight the importance of deﬁning the energy landscape of
amyloidogenic proteins in detail to allow prediction of their
amyloid propensity. The ﬁndings presented also suggest that
targeting a deﬁned non-native species should be a successful
means of controlling the fate of assembly of β2m and, in
principle, that of other amyloidogenic proteins which aggregate
via a speciﬁc, non-native precursor.
■ METHODS
Protein Preparation. The pINK plasmid containing the hβ2m,
mβ2m, or ΔN6 gene was transformed into E. coli cells of the BL21
DE3 plysS- strain. Starter cultures were generated by inoculating 100
mL of LB medium with cells containing the relevant gene and 50 μg/
mL carbenicilin and 50 μg/mL chloramphenicol and incubating
overnight at 37 °C, 200 rpm. 2 L ﬂasks containing 1 L of LB or HDMI
(1 g/L 15N-NH4Cl, 2 g/L
13C-glucose) medium were inoculated with
10 mL of starter culture. Cells were incubated at 37 °C, 200 rpm until
they reached an OD600 of ∼0.6 and then the expression of β2m was
induced by the addition of isopropyl β-D-1-thiogalactopyranoside
(IPTG-ﬁnal concentration of 1 mM). Expression was allowed to
continue overnight at 37 °C, and cells were harvested next morning
using a Heraus continual action centrifuge performing at 15 000 rpm.
The cell pellet containing β2m as inclusion bodies was chemically lysed
by the addition of 50−100 mL of lysis buﬀer (100 μg/mL lysozyme,
50 μg/mL DNase I, 50 μg/mL phenylmethylesulfonyl ﬂuoride
(PMSF), 10 mM Tris-HCl pH 8.0). Further cell disruption was
performed using a constant cell disrupter system (Constantsystems) at
a high pressure of 20.0 kpsi. Inclusion bodies were separated using
centrifugation (15 000 rpm using a Sorvall SS34 rotor) in a Beckman
centrifuge for 40 min at 4 °C, and the inclusion body pellet was
washed with 10 mM Tris-HCl pH 8.0 buﬀer four times. Finally, β2m
was solubilized in 10−20 mM Tris-HCl pH 8.0 (hβ2m, ΔN6) or 10−
20 mM Tris-HCl pH 8.5 (mβ2m) containing 8 M urea (MP
biomedicals) and refolded by dialysis (3000 MW cutoﬀ) against 2−5 L
of the same buﬀer but lacking urea. The refolded protein was
centrifuged for 30 min at 15000 rpm (Sorvall SS34 rotor) to pellet
insoluble material, and the supernatant was loaded on a Q-Sepharose
(GE Healthcare) column already equilibrated with 2 column volumes
of 20 mM Tris-HCl pH 8.0 (hβ2m, ΔN6) or 20 mM Tris-HCl pH 8.5
(mβ2m) for anion exchange puriﬁcation. Bound protein was eluted
Figure 1. Structure and amyloidogenicity of mβ2m. (A) The NMR structure of monomeric hβ2m (gray-2XKS
28) overlaid with the crystal structure of
mβ2m bound to the MHC-I complex (green-1LK2
38) or with the solution structure of ΔN6 (red-2XKU28). (B) Aggregation assay of 80 μM hβ2m
(gray), mβ2m (green), or ΔN6 (red) in 10 mM sodium phosphate buﬀer, pH 6.2 (three replicates for each protein). Negative stain electron
micrographs, color-coded with the same scheme, are shown on the right (scale bar = 500 nm). (C) The 1H−15N HSQC spectrum of mβ2m in the
same buﬀer as (B). (D) Correlation between experimental RDCs measured for mβ2m in 10 mg/mL phage PF1 and those back-calculated from the
crystal structure 1LK238 (R2 = 0.85).
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with a gradient of 0−400 mM NaCl (in the same buﬀer) over 800 mL
and was freeze-dried after dialysis in dH2O or concentrated using 3000
MW cutoﬀ centricons (Avanti LTD). Freeze-dried protein was
resuspended in 10 mM sodium phosphate buﬀer pH 7.0 (hβ2m,
ΔN6) and 10 mM sodium phosphate buﬀer pH 8.2 (mβ2m) ﬁltered
through 0.2 μm ﬁlters (Fisher Scientiﬁc) and gel-ﬁltered using a
HiLoad Superdex-75 Prep column (Amersham Biosciences), calibrated
with a standard gel ﬁltration calibration kit (GE Healthcare). The
monomer peak was collected, concentrated, aliquoted, and stored at
−80 °C or freeze-dried.
NMR Spectroscopy. Assignments of the backbone atoms of mβ2m
were obtained using samples of 500 or 750 μM uniformly labeled (15N,
13C) protein in 10 mM sodium phosphate buﬀer pH 6.2, 83.3 mM
NaCl, 0.02% (w/v) NaN3, and 10% (v/v) D2O. Three-dimensional
(3D) NMR experiments were recorded at 25 °C using Varian Inova
spectrometers (Agilent) operating at proton frequencies of 500 MHz
(HNCA, HNCO, CBCA(CO)NH, HN(CA)CO) and 750 MHz
(HNCACB), equipped with a room temperature or cryogenic probe,
respectively. Samples for H/D exchange experiments were prepared in
10 mM sodium phosphate buﬀer pH 6.2 and then freeze-dried. Freeze-
dried protein was dissolved in 100% (v/v) D2O containing 83.3 mM
NaCl and placed into the NMR tube after manual mixing. The loss of
intensity of amide proton resonances was then monitored by SOFAST
1H−15N HSQC31 spectra (5−10 min each) at 25 °C. Residual dipolar
coupling (RDC) experiments (J modulated series) were carried out
using a sample of 200 μM 15N-mβ2m in 10 mM sodium phosphate pH
8.2 and aligned in 11 mg/mL bacteriophage PF1 (Asla Scientiﬁc).
RDC data were back-calculated from crystal structures using PALES.32
For relaxation experiments, a sample of 80 μM 15N-mβ2m was
prepared in 10 mM sodium phosphate buﬀer at pH 6.2 with 10% (v/
v) D2O, 0.02% (w/v) NaN3, 83.3 mM NaCl. T2 experiments were
perfomed with 2048 and 128 complex points in the direct and indirect
dimension using 18.8, 37.7, 56. 6, 75.5, 94.4, 113.2, 132,1, 151.0 ms as
relaxation delays. The relaxation delays for the T1 experiments were
0.0.16, 0.32, 0.48, 0.64, 0.80, 0.96, 1.12, 1.44 s. For 1H−15N NOE
cross-relaxation experiments saturation of amide protons was achieved
with a train of 120° pulses for 3.5 s prior to the experiment. All
relaxation and RDC experiments were performed at 25 °C, using a 600
MHz Varian Inova spectrometer equipped with a room tempreature
probe. Direct carbon detection experiments were performed using a
sample of 13C, 15N mβ2m at 1.3 mM on a 950 MHz Bruker
spectrometer equipped with a cryogenic TCI probe (1024 and 160
complex points in the direct and indirect dimensions).
For real-time refolding experiments two refolding protocols were
followed: (1) protein samples were made in 10 mM sodium phosphate
buﬀer pH 6.2 and freeze-dried. Unfolding was performed by dissolving
the freeze-dried protein (2−3 mg) in 30−60 μL of the same buﬀer
containing 8 M urea at 37 °C for 1 h, and the protein was then
refolded by rapid 10-fold dilution in 10 mM sodium phosphate pH 6.2,
10% (v/v) D2O, and 0.02% (w/v) NaN3; (2) protein samples were
made in 250 μL of 10 mM sodium phosphate and 10% (v/v) D2O,
and the pH was adjusted to 2.0 (or pH 3.6) using Tris-HCl. Refolding
was then initiated by addition of 50 μL of 300 mM sodium phosphate
buﬀer, pH 7.2 (ﬁnal pH 6.1−6.3). Both refolding protocols were found
to give rise to similar spectra of the intermediate species. This
observation demonstrates that the increased ﬂexibility of the murine
intermediate (see Results) is not the result of the residual 0.8 M urea
present at the end of the ﬁrst refolding protocol. The refolding from IT
to native hβ2m was monitored by a series of SOFAST
1H−15N HSQC
spectra31,33 at 25 °C, with 80 increments in the indirect dimension,
two scans per increment and 512 complex points, resulting in a total
acquisition time of 45 s.
To assign the I1 state of mβ2m, refolding was monitored by
continuous acquisition of NUS NMR spectra. 3D HNCO+ and
HNCA+34 with a total acquisition time of ca. 17 h for each spectrum
and 2D 1H−15N BEST-TROSY35 were collected on separate samples
(800 MHz Bruker AVANCE III HD spectrometer with 3 mm TCI
cryoprobe). 2D 1H−15N BEST-TROSY, having the highest sensitivity,
was chosen as a reference spectrum to guide 3D spectra multidimen-
sional decomposition (MDD) coprocessing with a sliding time frame
window, resulting in a temporal resolution of a few minutes36 (see
Supplementary Methods).
To aid assignment of the real-time spectra, two samples were
prepared in which the early intermediate of mβ2m was highly
populated. The ﬁrst consisted of 600 μM of uniformly labeled 13C, 15N
mβ2m in 10 mM sodium phosphate and 10 mM sodium acetate pH
3.6, and the second consisted of 250 μM of uniformly labeled 13C, 15N
mβ2m in 10 mM sodium phosphate pH 6.2 with 1 M urea added. Both
samples gave rise to HNCA spectra that closely resembled the real-
time HNCA spectrum of the early intermediate of mβ2m. Additional
3D spectra were performed using these samples including HNCA,
HNCO, and CBCACONH utilizing a 600 MHz Varian Inova
spectrometer equipped with a room tempreature probe. TALOS+37
was used to predict the backbone order parameter (S2). TALOS+ uses
H, NH, Co, Cα, and Cβ backbone chemical shifts to calculate the
random coil chemical shift index which is then converted to backbone
S2. Aggregation assays performed on these samples conﬁrmed that the
early folding intermediate of mβ2m is not aggregation-prone.
Aggregation Assays. Samples containing 60 μM protein in 10
mM sodium phosphate buﬀer, pH 6.2, or 10 mM sodium phosphate,
with 10 mM sodium acetate pH 3.6, or in 10 mM sodium phosphate
buﬀer, pH 6.2, with 1 M urea, with the appropriate amount of NaCl
added to give a total ionic strength of 100 mM), 0.02% (w/v) NaN3
and 10 μM Thioﬂavin T (ThT) were incubated at 37 °C in sealed 96
well plates (Thermo Scientiﬁc) with agitation at 600 rpm.
Fluorescence was monitored at 480 ± 10 nm after excitation at 440
± 10 nm using a FLUOROstar Optima microplate reader (BMG
Labtech).
Equilibrium Unfolding. Urea stock solutions containing 75 mM
sodium phosphate buﬀer, pH 6.2, and either no urea or 10.5 M urea
were made, and the exact concentration of urea was determined using
the measured refractive index (Ceti refractometer). The stock
solutions were used to make samples of protein containing 0−10 M
urea in 0.2 M increments, with a ﬁnal protein concentration of 0.2 mg/
mL. Samples were incubated at 25 °C for 12 h before analysis using
tryptophan ﬂuorescence. Fluorescence was excited at 295 nm, and the
emission was monitored at 340 nm using a Photon Technology
International QM-1 spectroﬂuorimeter (PTI). The data were then
globally ﬁt to a two-state model:
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where ΔGoUF (kJ mol−1) is the equilibrium stability, MUF is the
equilibrium m-value, a and c represent the denaturant-dependence of
the folded and unfolded signal intensities, respectively, and b and d are
the signal intensities of the folded and unfolded states, respectively, in
the absence of denaturant.
Electron Microscopy (EM). Carbon coated copper grids were
prepared by the application of a thin layer of Formvar with an overlay
of carbon. Samples were centrifuged (14 000g, 10 min), and the pellets
were resuspended in fresh 10 mM sodium phosphate buﬀer, pH 6.2,
diluted to a ﬁnal protein concentration of 12 μM with deionized water
and then applied to the grid in a dropwise fashion. The grid was then
carefully dried with ﬁlter paper before it was negatively stained by the
addition of 18 μL of 2% (w/v) uranyl acetate. Micrographs were
recorded on a Philips CM10 or a JEOL JEM-1400 electron
microscope.
Stopped Flow Experiments. Experiments were performed using
an Applied-Photophysics SX1.8MV stopped-ﬂow ﬂuorimeter. The
temperature was held constant at 37 °C (±0.1 °C) using a Neslab
circulating water bath system. Experiments were performed in buﬀered
solutions containing 10 mM sodium phosphate (pH 6.2) and 83.3 mM
sodium chloride with or without 0.4 M sodium sulfate. Refolding
experiments were performed by 1:10 dilution of 80 μM protein in
buﬀer containing 8 M urea, into buﬀered solutions with ﬁnal urea
concentrations in the range 0.75−8.0 M. The ﬁnal urea concentration
ranged from 3.0 to 8.0 M for unfolding experiments. To obtain
refolding data at 0 M urea, a pH jump was performed by a 1:10
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dilution of 80 μM protein in 10 mM phosphate (pH 2.5) into 80 mM
sodium phosphate (pH 6.2). Data were normalized to the signal of the
folded and unfolded protein in 0 and 8 M urea, respectively. At each
urea concentration at least seven kinetic traces were obtained,
averaged, and ﬁtted to a single exponential function using the
manufacturer’s software. ΔGoUI1 was determined by plotting the
ﬂuorescence at the end point of a 20 s kinetic trace of folding against
urea concentration and by plotting the ﬂuorescence of the unfolded
state against urea concentration (in the latter case, the values at low
urea concentration were obtained by linear extrapolation from the
values at high urea concentration). The ﬂuorescence of the IT state
decreased with increasing urea concentration until it approached the
ﬂuorescence of the unfolded state. To estimate ΔGoUI1 at 0 M urea,
data were also recorded in the presence of 0.4 M Na2SO4 and the data
in 0 and 0.4 M Na2SO4 were ﬁtted globally to eq 1.
■ RESULTS
The native state of mβ2m is thermodynamically
unstable. As well as being 70% identical in sequence, mβ2m
and hβ2m/ΔN6 have similar structures (backbone RMSD ≈
1.5 Å) (Figure 1A). However, only ΔN6 is able to aggregate
into amyloid ﬁbrils at pH 6.2 as monitored by the increase in
ThT ﬂuorescence and by negative stain EM (Figure 1B), in
agreement with previous studies.19 To enable NMR studies of
mβ2m, chemical shift assignments were obtained for the native
monomeric protein using a range of 3D NMR experiments
(BMRB 19772) (85% of backbone atoms were assigned; see
Methods). The 1H−15N HSQC spectrum of native mβ2m at
pH 6.2 shows a single set of well-dispersed intense peaks,
characteristic of a folded protein in solution that undergoes
limited chemical exchange on the ms time scale (Figure 1C).
The only available structure of mβ2m is the crystal structure
of the protein bound to the heavy chain of the major
histocompatibility complex (MHC-I).38 In the case of hβ2m,
binding to the heavy chain causes conformational changes
particularly in the AB loop and the D strand of the protein.39
To determine whether the crystal structure of mβ2m bound to
the MHC-I complex constitutes a good representation for the
structure of the monomeric protein in solution, residual dipolar
couplings (RDC) were measured. Figure 1D shows that there is
excellent agreement (R2 = 0.85) between the measured RDCs
and those back-calculated from the crystal structure of MHC-I-
bound mβ2m (Figure 1D), conﬁrming the identity of the
solution structure of monomeric mβ2m with that bound to
MHC-I. Therefore, diﬀerences in the structures of the native
proteins cannot explain the diﬀerent amyloid potential of the
two variants.
We next assessed whether diﬀerences in thermodynamic
and/or kinetic stability between mβ2m and hβ2m/ΔN6 could
rationalize their diﬀerent amyloid propensity. Equilibrium
denaturation experiments revealed that mβ2m is less stable
than hβ2m (ΔΔG°un = −12.4 kJ/mol) (Figure 2A, 2B and
Supplementary Table 1). Remarkably, mβ2m is less stable than
the aggregation prone ΔN6 (Figure 2A, 2B) demonstrating
that thermodynamic instability cannot explain the inability of
mβ2m to form amyloid. Notably, ΔN6 shows a reduced m-
value compared with hβ2m and mβ2m, consistent with exposure
of hydrophobic residues that are normally buried in the core of
hβ2m (10 of the 17 core residues become more exposed in
ΔN628). Hydrogen exchange experiments monitored by
1H−15N HSQC spectra revealed that mβ2m is also kinetically
less stable than hβ2m, with amide protons exchanging with the
solvent more rapidly than hβ2m, while ΔN6 is the least
kinetically stable of the three proteins studied here (Figure 2C,
Figure S1A−C, and Figure S2). NMR relaxation experiments
on native mβ2m also showed no regions of increased dynamics
on the ps−ns time scale, apart from the DE loop which is
known to be ﬂexible in all β2m variants (Figure S2D−F). Thus,
there is no correlation between thermodynamic or kinetic
stability and amyloidogenicity of these diﬀerent β2m variants.
Real-Time Characterization of a Transient Folding
Intermediate. We next investigated whether the folding
pathway of mβ2m also involves transient formation of an
intermediate containing trans X-Pro 32 (known as the IT
state28), the accumulation of which has been shown to
correlate directly with the rate of amyloid formation of the
human protein.9 For these experiments, mβ2m was unfolded
either by incubating the protein at pH 2.0 or by the addition of
8 M urea at pH 6.2. Refolding was then initiated by dilution to
a buﬀer of pH 7.2 or to a buﬀer lacking urea (see Methods,
Figure S3), and NMR spectra were collected in real time to
track the refolding reaction in residue-speciﬁc detail. In the case
of hβ2m, and in accordance with previous studies,
28 a well-
dispersed spectrum was observed 3 min after refolding was
initiated, in which only small chemical shift diﬀerences are
detected in comparison with those of the native protein (Figure
3A and 3B). These results indicate that a native-like
intermediate (the IT state) accumulates during folding of
hβ2m, consistent with previous results.
9,28
As previously reported, the spectrum of ΔN6 is very similar
to that of the human IT state (Figure 3C).
28 In marked contrast
with the behavior of hβ2m, however, the
1H−15N HSQC
spectrum of mβ2m 3 min after refolding is initiated revealed
only ∼20 intense peaks with limited chemical shift dispersion in
the 1H dimension which coexist with the most intense peaks of
the native state (Figure 3D and 3E). Interestingly, the partially
folded state of mβ2m at pH 3.6 gives rise to a
1H−15N HSQC
spectrum that closely resembles the spectrum collected at pH ≈
6.2, 3 min after refolding was initiated (Figure 3F). These
Figure 2. Thermodynamic and kinetic stability do not correlate with
amyloid propensity. (A) Equilibrium denaturation curves for mβ2m,
hβ2m, and ΔN6 monitored using tryptophan ﬂuorescence (75 mM
sodium phosphate buﬀer pH 6.2, 25 °C). (B) Unfolding free energies
obtained by ﬁtting data in (A) to a two state model (see Table S1).
(C) Representative hydrogen exchange proﬁles for the amide
hydrogen of residue 83 in hβ2m, mβ2m, and ΔN6 at 25 °C and pH
6.2 (see Figure S2).
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results suggest that partially folded species are signiﬁcantly
populated during the folding of mβ2m, but that these species
diﬀer in structure and/or dynamics compared with their human
counterparts.
In order to assign the real-time spectrum of the intermediate
state of mβ2m, continuous, NUS NMR spectra (2D-BEST-
TROSY HSQC, 3D-HNCA+, and 3D-HNCO+) were collected
during refolding and the whole data set was coprocessed
together, resulting in a temporal resolution of a few minutes.36
Importantly, and in contrast with other real-time studies of
protein folding which consist of acquisition of sequential stand-
alone spectra,40 this NUS approach requires the acquisition of
only a single spectrum. Therefore, it does not require prior
knowledge about the folding reaction in order to decide on the
length of each individual experiment, since the time resolution
can be determined in the processing step. Additionally,
increased sensitivity is achieved by coprocessing less sensitive
3D NMR spectra (e.g., HNCA) with 2D experiments (e.g.,
HSQC).41
The same set of intense resonances shown in Figure 3E were
observed in 3D real-time spectra, consistent with these residues
being ﬂexible in the folding intermediate of mβ2m. As only 20
spin systems are present in the real-time HNCA spectrum,
assignment was challenging. To overcome this issue, further
backbone assignment experiments were performed on mβ2m at
pH 3.6 (Figure 3F) and mβ2m at pH 6.2 with 1 M urea added,
both of which gave rise to spectra similar to those of the kinetic
intermediate (Figure 3F and data not shown), removing the
need for rapid data acquisition (see Methods). The residue-
type speciﬁc information of the Cβ atoms from these
equilibrium experiments greatly facilitated the assignment of
the real-time HNCA spectrum.
The assignment walk on the Cα resonances of mβ2m 5 min
after folding was initiated is shown in Figure 4A. The
assignment revealed that all of the intense peaks shown in
Figure 3E correspond to residues located in the N-terminal
region, the A strand, and the AB loop of mβ2m (Figure 4B and
4C), regions of the polypeptide chain whose dynamics have
been implicated in the initiation of the aggregation of the
human protein.19,28 The C-terminal four residues of the protein
were also detected with chemical shifts that are diﬀerent
(ΔδH+N > 2 ppm) from those in the native structure. The
backbone assignments (N, NH, Cα, Cβ, CO atoms;
Supplementary Table 2) allow the accurate prediction of the
order parameter S2 and, therefore, an assessment of protein
dynamics. Figure 4B and 4C show that the 20 N-terminal
Figure 3. Folding of hβ2m and mβ2m in real-time. (A)
1H−15N SOFAST HSQC spectrum of native hβ2m in 10 mM sodium phosphate pH 6.2. (B)
The 1H−15N SOFAST HSQC spectrum of hβ2m collected 3 min after refolding was initiated by urea dilution. Peaks that are already in their native
positions are colored gray, while peaks with non-native chemical shifts are shown in red. (C) The 1H−15N HSQC spectrum of ΔN6 closely
resembles the spectrum of the real-time folding intermediate of hβ2m. An overlay of the spectra shown in B and C is shown as an inset. (D)
1H−15N
HSQC spectrum of native mβ2m in 10 mM sodium phosphate pH 6.2. (E) The
1H−15N BEST-TROSY-HSQC of mβ2m collected 3 min after
refolding was initiated by urea dilution. Peaks that are already in their native positions are colored green while peaks with non-native chemical shifts
are shown in purple. (F) The 1H−15N HSQC spectrum of mβ2m at pH 3.6 closely resembles the spectrum of the real-time folding intermediate of
mβ2m.
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residues show signiﬁcantly increased dynamics in the folding
intermediate in comparison with the native state, while the C-
terminal four residues, while visible, have conformational
dynamics similar to those of the native protein.
The molten-globule-like behavior of the intermediate state
(named here I1) prevents the direct observation of the majority
of the resonances (apart from the 20 most ﬂexible) in 1H-
detected experiments, as they are in conformational/solvent
exchange. To overcome this problem direct 13C-detection
experiments were performed on mβ2m at pH 3.6 in order to
obtain information about the structural properties of the rest of
the protein in the I1 state. These experiments revealed ∼80
resonances, 20 of which have sharp lines which correspond to
the 20 N-terminal residues assigned above. Other resonances
show broader lines suggesting that they correspond to residues
with a higher degree of folding (Figure S5). The far-UV CD
spectrum of mβ2m obtained 3 min after the pH jump from pH
2.0 to pH 6.2 shows that in I1 73% of native β-sheet structure is
already formed, as quantiﬁed by the ratio of the intensities at
219 nm (Figure 4D). These results show that mβ2m at pH 3.6
is partially structured, with the majority of residues being in a β-
sheet conformation, potentially native-like. These residues
undergo chemical exchange on the ms time scale (or exchange
rapidly with solvent) and, therefore, cannot be observed in the
1H−15N spectrum shown in Figure 3E.
In order to estimate the stability of the I1 state, stopped-ﬂow
ﬂuorescence experiments were used to determine the
ﬂuorescence intensity of mβ2m 20 s after folding was initiated
(Figure 4E). These experiments revealed that, by contrast with
the IT state of hβ2m for which the ΔG°un is −9.57 ± 0.54 kJ/
mol at 37 °C,9 the I1 state of mβ2m (ΔG°un = ∼−4.8 kJ/mol at
37 °C) is only marginally stable in solution, in accordance with
the real-time NMR data (Figure 4E). Overall, the data show
that mβ2m folds through a ﬂexible/molten globule-like
intermediate state in which the N-terminus and the A strand
are dynamic and detached from a native-like β-sandwich fold
(I1) (Figure 4C).
The ﬂexible intermediate I1 is not aggregation-prone.
The amyloid ﬁbrils of hβ2m are composed of parallel in register
β-strands,42,43 while in the native monomer the β-strands are all
antiparallel (Figure 1A). Thus, a major conformational change
has to occur on the pathway to ﬁbrils. Detachment of the A
strand might represent a ﬁrst step toward the remodeling of the
native protein, and therefore, the early intermediate of mβ2m,
I1, might be expected to be highly amyloidogenic. To test this
hypothesis, aggregation assays were performed using ΔN6 at
pH 6.2 as a mimic of the highly aggregation-prone state IT, and
mβ2m at pH 3.6, conditions which favor the less structured
intermediate state (I1) of mβ2m. Consistent with previous
results, these experiments showed that ΔN6 aggregates rapidly
at pH 6.2 with a lag time of ∼30 h, resulting in the formation of
amyloid ﬁbrils (Figure 5A). In marked contrast, no increase in
ThT ﬂuorescence was observed for mβ2m at pH 3.6 (Figure
5A). Indeed, the majority of the murine protein remained
soluble after 100 h of incubation, while ΔN6 was quantitatively
converted into amyloid ﬁbrils (Figure 5B and 5C). Interest-
ingly, the small amount of mβ2m that was not found in the
supernatant also formed short ﬁbrils ∼300 nm in length (Figure
5C). These results show that the partially folded state of mβ2m
is not highly aggregation prone. On the other hand, the speciﬁc
structural features of the native-like IT intermediate of hβ2m are
crucial for assembly.
A native-like IT intermediate is populated on the
pathway to native mβ2m. The data presented above
demonstrate that the conformational properties of the dynamic
I1 state of mβ2m are diﬀerent from those the native-like hβ2m IT
state. However, additional states could be populated after the
formation of I1 and prior to the formation of native mβ2m.
Indeed, as the folding time progresses a third set of peaks (apart
from the native and the ﬂexible intermediate states (Figure 3))
emerges in the real-time 1H−15N HSQC spectrum (Figure S4).
These peaks show small chemical shift diﬀerences compared
with the native mβ2m resonances and are generally broad
(Figure S4) suggesting that additional, more native-like states
are populated at later times during the folding of the protein.
This observation presumably reﬂects an ordered assembly
mechanism, in which the initially highly dynamic intermediate
(I1) folds to the native state via a transiently populated more
structured (IT-like) state.
To investigate this possibility further, partially folded mβ2m
at pH 3.6 (which mimics the I1 state − Figures 3E and 3F) was
allowed to fold by a rapid pH jump to pH 6.2 and folding was
monitored in real time using NMR. The 1H−15N HSQC
Figure 4. The early folding intermediate of mβ2m. (A) The
assignment walk on the Cα atoms of the real-time BEST-HNCA
spectrum of mβ2m collected 5 min after refolding was initiated by urea
dilution at pH 6.2. (B) Predicted S2 parameters for the folding
intermediate of mβ2m. The intense peaks shown in Figure 3E are
shown in dark blue. The S2 parameters of the native state are shown as
light blue bars and as a red line. (C) Residues observed in the real-time
spectrum of the folding intermediate are highlighted in red in the
structure of mβ2m. Pro 32 is shown as yellow spheres. (D) Far-UV CD
spectra of native mβ2m at pH 6.2 (green) and of the folding
intermediate 3 min after folding was initiated by a pH jump from pH
2.0 to pH 6.2 (red). (E) Normalized ﬂuorescence signal at the end of
each stopped-ﬂow transient (20 s) as a function of urea concentration
for mβ2m in the absence (red) or presence (black) of 0.4 M sodium
sulfate. The data were ﬁtted globally to a two-state model (see
Methods).
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spectrum collected 3 min after refolding was initiated showed a
well dispersed spectrum (Figure 6A) in striking and marked
contrast with the molten globule-like spectrum of the I1 state
shown in Figure 3E. Indeed, the spectrum obtained 3 min after
the pH jump is reminiscent of that of native mβ2m with
signiﬁcant chemical shift diﬀerences being limited to residues in
the N-terminal region (residues 1−6), the BC, DE, and FG
loops (Figure 6A and 6B). Moreover, the peaks that show
chemical shift diﬀerences from the native protein are
remarkably similar to the third set of peaks observed in Figure
S4B, consistent with folding from the partially folded state (I1)
to a more native-like intermediate (presumably IT). Impor-
tantly, residues that show signiﬁcant chemical shift changes are
surrounded by residues whose resonances are not detected in
the real-time NMR spectrum (Figure 6B). These areas reside in
close spatial proximity to Pro 32 in the native structure and,
therefore, are exchange-broadened. A similar scenario has been
observed for the real-time folding intermediate of hβ2m (IT).
40
Furthermore, ΔN6 shows chemical shift diﬀerences to native
hβ2m in these same regions.
28 Together, the results show that
mβ2m folds through a native-like intermediate state that has
similar structural properties to the amyloidogenic IT state of
hβ2m. However, due to its decreased stability, this species is
copopulated with an ensemble of partially folded, ﬂexible states
in which the N-terminal region is highly disordered (I1).
■ DISCUSSION
Characterization of Protein Energy Landscapes Using
Sparse Data. The results presented above highlight the
importance of determining the precise details of the folding
energy landscape of a protein in order to elucidate whether one
or more partially folded, or non-native states, have the potential
to initiate amyloid assembly. Characterization of ensembles of
interconverting non-native species that not only are lowly
populated but also have a short lifetime, such as those involved
in protein folding and aggregation, is a challenging task, even
for the most advanced biophysical methods. While time-
resolved NMR studies on proteins can be highly informative,
these studies usually suﬀer from low resolution and poor
sensitivity. By combining the use of sparsely sampled NMR and
coprocessing of more complicated/less sensitive experiments
with others that show increased sensitivity, we demonstrate
here the detection and atomic level depiction of the early
molten globule state, I1, of mβ2m, that is populated for only
∼15 min, a task that would not have been possible using
standard NMR methodologies (see Supplementary Methods).
The power of the real-time NMR experiments allowed us to
identify conditions that stabilize the I1 state (pH 3.6 or addition
of 1 M urea at pH 6.2) and to perform more detailed NMR
experiments on the trapped intermediate state that led to a
complete description of the folding mechanism of the murine
protein. The approach is potentially applicable to other
amyloidogenic proteins or proteins that fold through the
accumulation of transient intermediate states.
The precise balance between folding intermediates
determines the aggregation propensity of β2m. The
folding pathway of hβ2m has been investigated in detail over
Figure 5. Amyloidogenicity of intermediate states of mβ2m and hβ2m.
(A) ThT ﬂuorescence assays of 60 μM ΔN6 in 10 mM sodium
phosphate buﬀer pH 6.2 (red) or 60 μM mβ2m in 10 mM sodium
phosphate, 10 mM sodium acetate pH 3.6 (green). Five replicates are
shown for each protein. (B) SDS-PAGE gel of the end points shown in
(A). 20 μL of the reaction were spun down using a benchtop
centrifuge for 20 min and a sample of the total reaction (W) or of the
supernatant (S/N) after centrifugation, was analyzed by SDS-PAGE.
(C) AFM image of 60 μM mβ2m after 95 h of incubation (green in A,
note that ﬁbrils correspond to <5% of the protein added) and electron
micrograph of 60 μM ΔN6 (ﬁbrils correspond to >95% of the protein
added) after 95 h of incubation (red in A). Scale bar represents 500
nm.
Figure 6. Detection of a native-like folding intermediate for mβ2m.
(A) The 1H−15N SOFAST HSQC spectrum of mβ2m collected 3 min
after refolding was initiated from the partially folded state at pH 3.6
(blue), overlaid with the 1H−15N SOFAST HSQC of native mβ2m
(collected after 90 min) (gray). Peaks corresponding to the molten
globule I1 state are colored in pink. (B) Per residue combined
1H−15N
chemical shift diﬀerences between the native and the IT state of mβ2m,
using the spectra displayed in (A). Blue dots represent residues for
which assignments are missing in the native spectrum. Residues that
show chemical shift diﬀerences greater than 1 ppm (dashed line) are
colored yellow, those that show chemical shift diﬀerences less than 1
ppm are shown in gray, and residues that are broadened beyond
detection in the 3 min spectrum are colored red. The strucure of
mβ2m colored in the same color scheme is shown on the right.
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the past decade using diﬀerent protein variants and diﬀerent
techniques.9,28,44−48 Together, these studies have shown that
the folding of hβ2m involves the formation of a native-like
intermediate IT that is kinetically trapped by virtue of the non-
native trans X-Pro 32 bond.9,47 This species is preceded by a
less well characterized species (I1)
44 that forms in the dead time
of a stopped ﬂow experiment (<3 ms) and is less structured
than the IT state (Figure 7). The ﬁne details of the exchange
processes between these diﬀerent folding intermediates has a
dramatic eﬀect on the propensity to aggregate. For hβ2m the
structured aggregation-prone IT state is the most highly
populated species during folding, accumulating, on average, to
∼4% (pH 7.0, 37 °C) at equilibrium.9,10 By contrast, the
ﬂexible I1 state represents the most highly populated
intermediate state during the folding of mβ2m. Indeed, the
most intense peaks of the I1 state (but not those of the IT state)
are visible in the spectrum of native mβ2m, enabling estimation
of its equilibrium concentration to ∼7% (Figure S6). This
reduces the population of the mβ2m IT state, with the eﬀect that
aggregation no longer occurs (at least on an experimentally
tractable timescale) (Figure 7). Thus, although the folding
mechanisms of human and murine β2m are conserved (the
same species are populated on the pathway to the native state),
the precise balance between these states reduces the population
of the key amyloidogenic precursor IT for mβ2m and thus
deﬁnes the course of amyloid formation.
Interestingly, urea denaturation experiments on a partially
folded state of hβ2m formed at pH 3.6 have shown that the N-
terminal six residues and the A strand are the least stable
regions, while the rest of the protein forms a stable core.49
These results are consistent with the real-time NMR studies on
the I1 state of mβ2m presented here, showing that the
conformational properties of the early partially folded states
of hβ2m and mβ2m are similar. Interestingly, neither of these
states is able to form long, straight ﬁbrils characteristic of
amyloid, but instead they form short rod-like ﬁbrils (mβ2m at
pH 3.6) or worm-like ﬁbrils (hβ2m at pH 3.6)
50 (Figure 5).
A direct link between decreased native state stability and
increased aggregation propensity has been observed for several
proteins including lysozyme,51 transthyretin,6 and antibody
light chains.52 Accordingly, destabilizing mutations enhance the
rate of exchange between the native protein and partially folded
non-native species, which show increased amyloidogenicity
compared with the native state. Interestingly, mβ2m is less
thermodynamically and kinetically stable than hβ2m and, as a
consequence, the molten globule-like nonamyloidogenic I1
state is the most abundant non-native species (Figure 7). The
increased conformational dynamics results in a protein that is
unstable yet protected from amyloid assembly, since I1 is not
able to form amyloid. These ﬁndings argue against a simple link
between native state stability and amyloidogenicity (at least for
β2m). Instead, they highlight the importance of the precise
conformational properties of the native-like IT state that are
vital for assembly.
Together, the results demonstrate that amyloid formation of
β2m at neutral pH is initiated via the highly structured IT state.
Hence, from the myriad of potential non-native conformations
that could be populated during folding, only the IT state allows
the entrance of β2m to the aggregation landscape (Figure 7).
Such a ﬁnding highlights the ordered speciﬁcity in the early
stages of assembly into amyloid and opens the opportunity to
target a speciﬁc non-native state in order to control the onset of
aggregation, for example through the development of antibod-
ies, nanobodies, or small molecules that speciﬁcally recognize
this species. The results highlight the importance of considering
multiple factors in order to predict amyloid formation.
Hydrophobicity, the propensity of the sequence to aggregate,
the stability of the native state, solubility, transient exposure of
aggregation-prone regions through protein dynamics, and the
stability of the polypeptide sequence within the fully assembled
ﬁbril structure itself, may all contribute to enhanced
amyloidogenicity. Although, these factors are well understood
individually, the interplay between them during aggregation
remains poorly explained. The results presented emphasize the
importance of understanding the energy landscape of
aggregation in intricate detail, from both thermodynamic and
kinetic view points, in order to predict whether or not a protein
will aggregate and how/why minor alterations in solution
Figure 7. Balance between protein folding and aggregation. The native-like IT state is predominantly populated during the folding of hβ2m (gray
scheme, left). This allows the entrance to the aggregation landscape (red scheme) as IT shows enhanced amyloidogenicity. In the case of mβ2m
(right) IT represents only a minor conformation during folding, but instead the ﬂexible molten globule-like state in which the A strand is detached
from the β-sandwich fold is the major non-native species. As I1 is not aggregation-prone, mβ2m is protected from misfolding and instead folds to the
native state (the energy levels of the aggergation landscape are drawn for illustration purposes only).
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conditions/amino acid sequence can have a dramatic eﬀect on
the course of assembly, by small changes in the relative
populations of amyloidogenic versus nonamyloidogenic states.
■ CONCLUSION
In this study we have used NUS NMR methods to study the
relationship between protein folding and aggregation of a
globular protein that forms amyloid ﬁbrils from a structured
precursor state, using β2m as the test protein. We show that the
least thermodynamically stable protein is the least aggregation-
prone sequence of the family of proteins studied here. Analysis
of the folding energy landscape of the protein using real-time
NMR revealed that the decreased stability and decreased
lifetime of a precise and well-deﬁned native-like amyloidogenic
precursor (IT) are suﬃcient to tip the balance from aggregation
to folding. The power of sparsely sampled NMR allowed us not
only to detect a dynamic intermediate state (I1) of mβ2m but
also to structurally characterize this species in residue-speciﬁc
detail. The results reveal that the least stable protein (mβ2m)
populates predominantly a ﬂexible intermediate (I1) that is not
aggregation-prone, while its more stable counterpart (hβ2m)
folds through a native-like intermediate that has enhanced
amyloidogenicity. Subtle changes in the folding energy
landscape thus lead to dramatic changes in the aggregation
outcome. The results reveal that protein stability does not
correlate with aggregation propensity. Instead it is the precise
balance and kinetic partitioning of intermediate states that
determines whether β2m will fold to the native state or
aggregate to form amyloid ﬁbrils.
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